Safety, Tolerability, and Preliminary Efficacy of Peginterferon α-2b in Combination With an Anti-PD-1 Antibody in Patients With Advanced or Metastatic Malignant Solid Tumors
Clinical trial NCT07438093 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07438093
- Sponsor
- The First Affiliated Hospital of Xiamen University
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-01
- Primary completion
- 2027-04-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.